Millions in funding to revolutionize immunotherapy

Swiss start-up NXI Therapeutics extends pre-seed financing to CHF 3.5 million in run-up to larger seed financing

25-Jun-2024
Computer-generated image

Symbolic image

NXI Therapeutics AG, developer of tomorrow’s disruptive immunotherapies by coronin 1 modulation, announces the extension of a pre-Seed financing totalling to 3.5 million CHF. This financing extension comes in the run-up to a larger Seed financing that the company is currently raising. Kickfund joins a group of investors including lead investor JFG Life Sciences Foundation, BaseLaunch and Venture Kick. NXI has also been supported by an InnoBooster grant from the Gebert Rüf Foundation and a Propelling grant from the University of Basel.

Further, Patrick Burgermeister, CEO of the JFG Life Sciences Foundation, will join the company’s Board of Directors. He has a highly relevant background with prior positions in venture capital (BioMedPartners), pharma (Novartis) and banking (Zürcher Kantonalbank). He holds Master’s degrees in Molecular Biology from the University of Basel and in Business Administration from the University of St. Gallen (HSG).

About coronin 1 modulation

Coronin 1 depletion in preclinical models allows long-term acceptance of genetically unrelated organ transplants, prevents Graft versus Host Disease (GvHD), protects from several autoimmune disorders and at the same time allows to maintain a normal life span without infections and emergence of cancer, a frequent complication of contemporary immunosuppressants. Thus, modulating the coronin 1 pathway holds great potential for more effective and safer treatments for autoimmune diseases, as well as for transplantation medicine.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Something is happening in the life science industry ...

This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.